Mindray Medical (MR) Announces FDA 510(k) Clearance for AS3000 Anesthesia Delivery System
More News related to MR
- Mindray Medical International Announces Second Quarter 2008 Results
- Mindray Medical (MR) Appoints Liu as COO
- Mindray Appoints Jie Liu as Chief Operating Officer
- Mindray Releases Historical Financial Results Converted into US Dollar Terms
- Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
Mindray Medical International Limited (NYSE: MR) received 510(k) clearance from the FDA for its AS3000 next generation anesthesia delivery system developed by Datascope Patient Monitoring, a Mindray company.
The AS3000 delivers precision anesthesia and ventilation assistance with an intuitive design developed to bring a higher level of ergonomics to the operating room. The AS3000 is designed specifically to penetrate the anesthesia delivery systems market within the U.S., which is a market that the company estimates will generate approximately US$250 million in 2008.
Related Categories
FDAStocks Mentioned
+0.39Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
